Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.

about

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.

Item

http://www.wikidata.org/entity/Q54234367

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Hepatitis B infection reported ...... dverse Event Reporting System.

@en

Hepatitis B infection reported ...... dverse Event Reporting System.

@nl

type

Item

label

Hepatitis B infection reported ...... dverse Event Reporting System.

@en

Hepatitis B infection reported ...... dverse Event Reporting System.

@nl

prefLabel

Hepatitis B infection reported ...... dverse Event Reporting System.

@en

Hepatitis B infection reported ...... dverse Event Reporting System.

@nl

P1476

Hepatitis B infection reported ...... Adverse Event Reporting System

@en

P2093

Masahiro Kondo

http://www.w3.org/2001/XMLSchema#string

Ryohei Nishikawa

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Maeda

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Kawade

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Ogawa

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism.

Decision support methods for the detection of adverse events in post-marketing data.

Bortezomib induced hepatitis B reactivation.

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

P304

2269-2279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1429

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29663729

http://www.w3.org/2001/XMLSchema#string

P932

6010750

http://www.w3.org/2001/XMLSchema#string